feed,title,long_url,short_url
Benzinga,vTv Therapeutics Presents Baseline Characteristics of the Enrolled Subjects in the Elevage Study Suggesting Comparability to the Post-Hoc Diabetes Subgroup of the Phase 3 STEADFAST Study,https://www.benzinga.com/pressreleases/20/11/g18204621/vtv-therapeutics-presents-baseline-characteristics-of-the-enrolled-subjects-in-the-elevage-study-s,https://j.mp/2TSuR3Y
Benzinga,Stryker announces receipt of all required regulatory approvals for proposed acquisition of Wright Medical,https://www.benzinga.com/pressreleases/20/11/g18204619/stryker-announces-receipt-of-all-required-regulatory-approvals-for-proposed-acquisition-of-wright-,https://j.mp/3jWHd5J
Benzinga,Kura Oncology to Participate in Three Upcoming Investor Conferences,https://www.benzinga.com/pressreleases/20/11/g18204618/kura-oncology-to-participate-in-three-upcoming-investor-conferences,https://j.mp/2TT0Ile
Benzinga,"Agile Therapeutics to Host Third Quarter 2020 Financial Results Conference Call and Provide Corporate and TwirlaÂ® Commercial Updates on Thursday, November 12, 2020",https://www.benzinga.com/pressreleases/20/11/g18204617/agile-therapeutics-to-host-third-quarter-2020-financial-results-conference-call-and-provide-corpor,https://j.mp/34Y9LaS
Benzinga,Salarius Pharmaceuticals to Report Third Quarter 2020 Financial Results,https://www.benzinga.com/pressreleases/20/11/g18204613/salarius-pharmaceuticals-to-report-third-quarter-2020-financial-results,https://j.mp/3oW24K3
